Article
Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
European heart journal - 7 Oct 2017
Castaño Adam, Narotsky David L, Hamid Nadira, Khalique Omar K, Morgenstern Rachelle, DeLuca Albert, Rubin Jonah, Chiuzan Codruta, Nazif Tamim, Vahl Torsten, George Isaac, Kodali Susheel, Leon Martin B, Hahn Rebecca, Bokhari Sabahat, Maurer Mathew S
Abstract excerpt
AIMS: Transthyretin cardiac amyloidosis (ATTR-CA) has been reported in patients with aortic stenosis (AS) but its prevalence and phenotype are not known. We examine elderly patients with severe symptomatic AS undergoing transcatheter aortic valve replacement (TAVR) and determine the prevalence and phenotype of ATTR-CA non-invasively. METHODS AND RESULTS: We performed technetium-99m pyrophosphate (99mTc-PYP)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.